Doorgaan naar inhoud

Sikkelcelziekte

Behandeling van vaso-occlusieve crisen en acute chest syndrome

Pijnbestrijding

What is the best pharmacologic treatment for sickle cell disease pain crises? (opent nieuw venster)

Baker M, Hafner JW.

Bron‎: Ann Emerg Med 2012;59(6):515-6.

Geïndexeerd‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (opent nieuw venster)

Update on pain management in sickle cell disease. (opent nieuw venster)

Ballas SK.

Bron‎: Hemoglobin 2011;35(5-6):520-9.

Geïndexeerd‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (opent nieuw venster)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (opent nieuw venster)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Bron‎: Thromb Haemost 2007;98(2):392-6.

Geïndexeerd‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (opent nieuw venster)

Hydratietherapie (vochtbeleid)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (opent nieuw venster)

Okomo U, Meremikwu MM.

Bron‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Geïndexeerd‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (opent nieuw venster)

Zuurstofsuppletie

Guidelines for the management of the acute painful crisis in sickle cell disease. (opent nieuw venster)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Bron‎: Br J Haematol 2003;120(5):744-52.

Geïndexeerd‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (opent nieuw venster)

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (opent nieuw venster)

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

Bron‎: Diving Hyperb Med 2012;42(2):82-4.

Geïndexeerd‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 (opent nieuw venster)

Antibiotica- en luchtwegtherapie

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (opent nieuw venster)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Bron‎: Hemoglobin 2004;28(2):85-102.

Geïndexeerd‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (opent nieuw venster)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (opent nieuw venster)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

Bron‎: N Engl J Med 1995;333(11):699-703.

Geïndexeerd‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (opent nieuw venster)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (opent nieuw venster)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

Bron‎: J Investig Med 2008;56(8):1023-7.

Geïndexeerd‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (opent nieuw venster)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (opent nieuw venster)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

Bron‎: N Engl J Med 2000;342(25):1855-65.

Geïndexeerd‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (opent nieuw venster)